A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure

NATerminatedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

July 31, 2024

Conditions
Diabetes
Interventions
DEVICE

LIFELEAF Smartwatch

Noninvasive wearable smartwatch/monitor that utilizes photoplethysmography (PPG) which is a set of measurements acquired from the light flashed from the back of the watch and measuring the intensity of the reflected light from the blood in the blood vessels just below the skin at the wrist. Provides a non-invasive method for measuring blood glucose as well as alternative method for measuring blood pressure, heart rate and rhythm, etc.

Trial Locations (1)

55905

Mayo Clinic Minnesota, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05904769 - A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure | Biotech Hunter | Biotech Hunter